Project: A therapeutic vaccine to eradicate pre-malignant HPV16 and HPV18 infection and prevent cancer
| Acronym | THERIN (Reference Number: 12151) |
| Duration | 03/07/2018 |
| Project Topic | The consortium has 3 Goals: Commercial: Deliver proof-of-concept for elimination of pre-existing papillomavirus infection in non-human primates and a human candidate vaccine ready to enter clinical development. Science advance: The first therapeutic HPV vaccine in humans matching prophylactic vaccines in efficacy Social impact: Substantial prevention of virus-induced cancer on a global scale with the potential to lower healthcare expenses |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 8 |